Back to Trades
Goeltz II Robert C.
Chief Financial OfficerCIK 0001653881
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 3
- Buy transactions
- 0
- Sell transactions
- 3
- Companies
- 1
- Active
- 2025–2026
Goeltz II Robert C., Chief Financial Officer, has filed 3 SEC reports (2025–2026), all concentrated in Arcus Biosciences, Inc. (RCUS), totaling $2.5M in disclosed volume. Weighing $0 bought versus $378.7K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Jan 26 | RCUS Arcus Biosciences, Inc. | Goeltz II Robert C. | Chief Financial Officer | Grant | $2.1M |
| Dec 18 | RCUS Arcus Biosciences, Inc. | Goeltz II Robert C. | Chief Financial Officer | Sell | $278.7K |
| Oct 29 | RCUS Arcus Biosciences, Inc. | Goeltz II Robert C. | Chief Financial Officer | Sell | $100.0K |
3 filings